Searched for
HEPATITIS B
Hanuman Ansh, now a Rs 316 crore blockbuster, almost didn’t get made; lead actor left. Director reveals, 'He vomited 40 times…'Hanuman Ansh is one of the highest-grossing movies this year, crossing Rs 300 crore at the box office. However, the movie almost didn’t mat...- US refusals of crucial newborn vitamin spike, raising risk of dangerous bleedingUS hospitals report a significant rise in vitamin K shot refusals for newborns. This trend has accelerated sharply this year, increasing li...
- Zydus’ Saroglitazar meets primary goal in global Phase II(b) MASH trialZydus Lifesciences said its drug Saroglitazar Magnesium met the primary goal of a global Phase II(b) trial for MASH, a serious liver diseas...
- Molbio Diagnostics shares rally 6% after strong debut. What should investors do?Molbio Diagnostics made a strong debut, beating grey market expectations. Experts remain positive on the company’s molecular diagnostics le...
- Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSEMolbio Diagnostics Share Price: Molbio Diagnostics made a strong stock market debut, listing at a 21.44% premium over its IPO price of Rs 8...
- Blood donation camps don’t qualify for GST exemption, Gujarat AAR rulesGujarat's AAR ruled blood donation camps are not charitable for GST exemption. Yoga camps, however, were deemed charitable activities and e...
- Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check statusMolbio Diagnostics IPO allotment is expected on Thursday after the Rs 939.70-crore issue was subscribed 70.26 times. With a grey market pre...
- US President Donald Trump's childhood vaccine order: What it does and what doctors sayPresident Donald Trump signed an executive order reducing routine childhood vaccinations. The order also directs the Justice Department to ...
- Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broad...
- Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPOMolbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public offering. T...
- Over 5 lakh UK visas issued to Indians as Britain completes eVisa rolloutIndia remains a key UK travel market, with over 500,000 visas granted to its citizens. The United Kingdom has fully transitioned to a digit...
- Indian Consulate in Dubai prioritises Tatkal passport backlog, aims for zero pendency before Independence DayThe Indian Consulate in Dubai is clearing urgent passport applications before Independence Day. Priority is given to Tatkal category applic...
- New Zealand eases resident visa health rules; Hepatitis B, C no longer automatic hurdleNew Zealand has eased health assessment rules for resident visa applicants. Hepatitis B and C are no longer high-cost conditions for migran...
- Molbio Diagnostics IPO to open on August 10, price band set at Rs 768-807Molbio Diagnostics is set to launch its IPO on August 10, 2026, with a price band of Rs 768-807 per share. The Rs 939.70 crore public issue...
- Not just alcohol addiction. Doctor explains one common pantry habit may increase risk of liver cancer: 'When peanuts, corn or grains sit in warm, humid pantries...'Eating stale peanuts, or peanuts which have been stored in damp and humid conditions can inadvertently make you more susceptible to cancer ...
- GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studiesGSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achievi...
- Evidence confirms U.S. newborn Hepatitis B vaccination policy amid calls to delayAn independent review of more than 400 studies confirms that the U.S. policy of providing the hepatitis B vaccine to newborns has reduced c...
- Odisha declares Hepatitis B and C as notifiable diseasesThe state government of Odisha in India declared Hepatitis B and C as notifiable diseases due to their emergence as major health problems. ...
- Hepatitis B, C may up Parkinson's disease risk, shows studyPeople with hepatitis B are 76 per cent more likely to develop Parkinson's disease.
- India has the second highest number of Hepatitis B infectedEvery year, nearly 600,000 patients die from HBV infection in the region but the govt doesnt yet have national policies relating to screeni...
Load More
